臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 211-235 / 690 (共28页)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-01T01:54:28Z	Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; Huang S.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:28Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:27Z	Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma	Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Tzeng Y.-S.; Chen J.-Y.; Hsu P.-N.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:27Z	NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells	Gao M.; Yeh P.Y.; Lu Y.-S.; Chang W.C.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:27Z	Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma	Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:26Z	Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional Recurrence	Kuo S.-H.; Huang C.-S.; Kuo W.-H.; ANN-LII CHENG; Chang K.-J.; Chia-Hsien Cheng J.
臺大學術典藏	2021-09-01T01:54:26Z	OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma	Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:26Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:25Z	Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy	Lin Y.-C.; Wei L.-H.; Shun C.-T.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:25Z	Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway	Dai H.-Y.; Hong C.-C.; Liang S.-C.; Yan M.-D.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:25Z	Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells	Lin H.-J.L.; Zuo T.; Lin C.-H.; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; ANN-LII CHENG; Ostrowski M.C.; Huang T.H.-M.
臺大學術典藏	2021-09-01T01:54:24Z	Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy	Hsu C.; Wei S.-C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏	2021-09-01T01:54:24Z	National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital	Lin C.-C.; Yang C.-H.; ANN-LII CHENG; Chan W.-K.; Ho N.-N.
臺大學術典藏	2021-09-01T01:54:24Z	Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial	ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z.
臺大學術典藏	2021-09-01T01:54:23Z	The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma	Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:23Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:23Z	Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application	Lee J.-H.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏	2021-09-01T01:54:22Z	Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment	Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; Tien Y.-W.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:22Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients	Chen C.-H.; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; ANN-LII CHENG; Chen D.-S.; Wang J.-D.; Sheu J.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study	Faivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Lamivudine and hepatitis B reactivation	Hsu C.; ANN-LII CHENG; Chen P.-J.

显示项目 211-235 / 690 (共28页)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51187276 在线人数 : 590 教育部委托研究计画计画执行:国立台湾大学图书馆